Search clinical trials for: Mineralocorticoid receptor antagonists

Total 41081 results

West Virginia University Healthcare

Unknown

Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease

Chronic Lung Disease | Bronchopulmonary Dysplasia

United States
Subha Raman
Ballou Skies

Completed

Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy (E-SCAR DMD)

Duchenne Muscular Dystrophy

United States
University College, London
British Heart Foundation

Completed

Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size (MINIMISE-STEMI)

ST-elevation Myocardial Infarction

United Kingdom
Semmelweis University

Completed

Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

Chronic Central Serous Chorioretinopathy

Hungary
Parc de Salut Mar

Completed

Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.

Resistant Arterial Hypertension

Spain
GlaxoSmithKline

Completed

Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.

Diabetes Mellitus

France, Poland, Germany, Netherlands, Spain, Greece, Slovakia, Italy, United Kingdom, Denmark, Belgium, Norway, Canada, Israel
Yonsei University

Withdrawn

A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)

Congestive Heart Failure
University of Florida

Withdrawn

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Female Androgenetic Alopecia

United States
Cairo University

Completed

The Effect of Oral Contraceptives on Women Balance

Joint Stabilioty

Egypt
Estetra

Completed

Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers

Contraception
Brigham and Women's Hospital
Bayer

Completed

Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

Cardiovascular Diseases

United States
Svendborg Hospital
Takeda; Region of Southern Denmark

Unknown

Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation (INSPIRE-AF)

Atrial Fibrillation

Denmark
Navy General Hospital, Beijing

Unknown

Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

Primary Ovarian Insufficiency | Menopause, Premature

China
The University of Texas Health Science Center at...

Withdrawn

High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure

Heart Failure

United States
Radboud University Medical Center

Completed

Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment (PAGODE)

Primary Aldosteronism | Primary Hyperaldosteronism

Netherlands
University of Pavia

Completed

Canrenone as Add-on in Patients With Essential Hypertension

Essential Hypertension
Institut National de la Santé Et de la Recherche...

Completed

Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis

Central Serous Chorioretinitis

France
Emma Nilsson
Karolinska University Hospital; Göteborg University; University Hospital, Linkoeping and other collaborators

Withdrawn

Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects

Cirrhosis | Ascites

Sweden
Bayside Health
Baker Heart and Diabetes Institute

Unknown

Eplerenone in the Management of Abdominal Aortic Aneurysms

Aortic Aneurysm, Abdominal

Australia
Radboud University Medical Center

Completed

The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium (EPLICARD)

Ischemia-reperfusion Injury

Netherlands
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

Eplerenone in Hemodialysis Trial (PHASE)

Hemodialysis | End Stage Renal Disease

Canada
Bayer

Completed

GA YAZ ACNE in China Phase III

Acne Vulgaris

China
Regional Hospital Holstebro

Completed

The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables (hass)

Essential Hypertension

Denmark
Hospital de Clinicas de Porto Alegre

Completed

Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea (DESALT)

Obstructive Sleep Apnea

Brazil
Instituto Nacional de Ciencias Medicas y Nutricion...

Terminated

Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B

Patients With Fungic Infections

Mexico
Assistance Publique - Hôpitaux de Paris
Société de Dermatologie Française

Completed

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy (SPIREPI)

Cutaneous Atrophy Due to Corticosteroids

France
University of Cambridge
British Heart Foundation

Unknown

Optimum Treatment for Drug-Resistant Hypertension (PATHWAY2)

Hypertension, Resistant to Conventional Therapy

United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Aldosterone Blockade Early After Acute Myocardial Infarction (ALBATROSS)

Myocardial Infarction

France
Monash University
National Heart Foundation, Australia

Completed

SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)

Heart Failure

Australia
Washington University School of Medicine
University of Pennsylvania

Withdrawn

CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression

Hypertension

United States
Bayer

Completed

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Hypertension | Postmenopause | Pre-Hypertension

United States
Texas Tech University Health Sciences Center

Withdrawn

Aliskiren and Renin Inhibition in Diastolic Heart Failure (ARID-HF)

Diastolic Heart Failure

United States
Baylor College of Medicine
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
Bayer

Completed

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Sobngwi Eugene
University of Yaounde 1

Completed

Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension (SPIRY)

Diabetes Mellitus | Hypertension, Resistant to Conventional Therapy

Cameroon
Bayer

Completed

Cycle Control and Safety of E2-DRSP

Contraceptive, Oral, Hormonal

Germany
Instituto Nacional de Cardiologia Ignacio Chavez
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Unknown

Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery

Kidney Injury, Acute | Acute Renal Injury | Acute Kidney Injuries | Kidney Injuries, Acute | Acute Renal Injuries

Mexico
Mahidol University

Unknown

Comparison of Body Weight Change During Contraception With Belara and Yasmin

Body Weight Changes

Thailand
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function (TOPCAT)

Heart Diseases | Cardiovascular Diseases | Heart Failure, Congestive

United States, Canada, Brazil, Argentina, Georgia, Russian Federation
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Contraceptives Containing Drospirenone and Blood Pressure

Blood Pressure | Contraception

Brazil
Bayer

Completed

Treatment of Vasomotor Symptoms in Korean Post Menopausal Women

Vasomotor Symptoms

Korea, Republic of
Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
University of Toledo Health Science Campus

Completed

Hemodynamic Effects of Spironolactone in Patients With Heart Failure

Congestive Heart Failure

United States
Bayer

Completed

A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

Contraception

Germany
Tyumen State Medical Academy

Unknown

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Hyperandrogenism | Polycystic Ovarian Syndrome | Menstrual Irregularities

Russian Federation
Bayer

Completed

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

Contraception

Netherlands, Canada, Germany
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Austria
Second Xiangya Hospital of Central South University
Baxter Healthcare Corporation

Unknown

Residual Renal Function Preservation in Peritoneal Dialysis Patients

Chronic Renal Disease

China
Instituto Nacional de Cardiologia Ignacio Chavez

Suspended

Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

Kidney Transplant

Mexico
Bayer

Withdrawn

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

Contraception

Search clinical trials for: Mineralocorticoid receptor antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations